Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer

Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer

Small-cell lung cancer (SCLC) is an aggressive, neuroendocrine tumour with high relapse rates, and significant morbidity and mortality. Apart from advances in radiation therapy, progress in the systemic treatment of SCLC had been stagnant for over three decades despite multiple attempts to develop a...

Full description

Bibliographic Details
Main Authors: Barbara L. Melosky, Natasha B. Leighl, David Dawe, Normand Blais, Paul F. Wheatley-Price, Quincy S.-C. Chu, Rosalyn A. Juergens, Peter M. Ellis, Alexander Sun, Devin Schellenberg, Diana N. Ionescu, Parneet K. Cheema
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Current Oncology
Subjects:
extensive stage small-cell lung cancer
immune checkpoint inhibitors
PD-L1
PD-1
platinum
etoposide
Online Access:https://www.mdpi.com/1718-7729/30/7/465

Internet

https://www.mdpi.com/1718-7729/30/7/465

Similar Items